flowers gif 

Originally posted by naturegifs

Treatments for Alzheimer’s disease can be expensive to produce, but by using novel cultivation of daffodils, one small Welsh company has managed to find a cost-effective production method of one pharmaceutical drug, galanthamine. 

The disease has been identified as a protein misfolding disease which leads to the break down, or death, of neurons and synapses in the brain. The pathology of the disease is complicated and involves many processes and enzymes.

 brain xray

Alzheimer’s disease is the cause of 60-70% of dementia cases. 

Alzheimer’s disease is a neurodegenerative disease with a range of symptoms, including language problems, memory loss, disorientation and mood swings. Despite this, the cause of Alzheimer’s is very understood. The Alzheimer’s disease drug market is currently worth an estimated US$8bn. 

The main current form of treatment is acetylcholinesterase inhibitors(AChEIs). Acetylcholine is a neurotransmitter that is mainly involved in motor function, particularly in muscles, and its production has been found to decrease in Alzheimer’s patients as they age. AChEIs inhibit the breakdown of acetylcholine, strengthening the brain’s responses. 

Agroceutical Products: on the road to sustainable Alzheimer’s medication. Video: Innovate UK  

Galanthamine is a natural product that is also an acetylcholinesterase inhibitor. It has been used in medicine since the 1950s and is commonly used for the treatment of Alzheimer’s disease. The drug can be isolated in small quantities from flowers such as Caucasian snowdrop, daffodils and red spider lilies, or produced synthetically at a high cost.